Heart Failure

Clinical Trial Finder

Many patients with heart failure are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Diltiazem vs. Metoprolol in the Acute Management of AF in Patients With HFrEF

Conditions:   Atrial Fibrillation;   Heart Failure
Intervention:   Drug: Metoprolol vs Diltiazem
Sponsors:   RaeAnn Hirschy;   Kimberly Ackerbauer, PharmD, BCPS, BCCCP;   Gary Peksa, PharmD, BCPS;   Joshua DeMott, PharmD, BCPS, BCCCP;   Paul O'Donnell, PharmD, BCPS, BCCCP
Active, not recruiting - verified October 2016

Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency

Conditions:   Iron Deficiency;   Heart Failure
Interventions:   Drug: ferric carboxymaltose;   Other: Normal saline 0.9%
Sponsors:   Vifor Inc.;   Worldwide Clinical Trials;   Cytel Inc.
Not yet recruiting - verified September 2016

A Novel Fully Integrated Mobile Management Solution Using Cell Phone Technology for Heart Failure

Condition:   Heart Failure
Intervention:   Other: Cell Phone
Sponsors:   University of Miami;   James and Esther King Biomedical Research Program
Completed - verified October 2016

Researching Emotions And Cardiac Health (REACH): Phase II

Conditions:   Congestive Heart Failure;   Emotions;   Patient Compliance
Intervention:   Behavioral: PP-based health behavior intervention
Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified October 2016

Does Cyclosporine ImpRove Clinical oUtcome in ST Elevation Myocardial Infarction Patients at 3 Years of Follow-up. CIRCUS II Study

Condition:   ST Elevation Acute Myocardial Infarction
Interventions:   Drug: Injection of Cyclosporin;   Drug: Placebo;   Procedure: Echocardiography
Sponsor:   Hospices Civils de Lyon
Recruiting - verified October 2016

Correlation of SOZO BIS Measures With CardioMEMS PA Pressure

Condition:   NYHA Class III Heart Failure
Sponsors:   ImpediMed Limited;   Harvard Clinical Research Institute;   Scripps Health
Not yet recruiting - verified October 2016

4 Cities for Assessing CAlcification PRognostic Impact After TAVI

Condition:   Heart Disease
Intervention:   Device: Transcatheter Aortic Valve Implantation (TAVI)
Sponsor:   Hospices Civils de Lyon
Recruiting - verified October 2016

Vitamin D and Cardiovascular Events in Rheumatoid Arthritis

Conditions:   Rheumatoid Arthritis;   Cardiovascular Disease
Interventions:   Other: Baseline serum vitamin D level below 50 nmol/l;   Other: Baseline serum vitamin D level at or above 50 nmol/l
Sponsors:   Odense University Hospital;   The Danish Rheumatism Association;   University of Southern Denmark;   Region of Southern Denmark;   Pfizer;   Odense Patient Explorative data Network (OPEN)
Completed - verified October 2016

Study With Healthy Japanese and Non-Asian Participants With BMS-986231

Condition:   Heart Decompensation, Acute
Interventions:   Drug: BMS-986231;   Drug: BMS-986231 Placebo
Sponsor:   Bristol-Myers Squibb
Not yet recruiting - verified October 2016

Micra Accelerometer Sensor Study 2

Condition:   Bradyarrhythmia
Intervention:   Device: Investigational Software loaded on Micra device
Sponsor:   Medtronic Cardiac Rhythm and Heart Failure
Not yet recruiting - verified October 2016

Clinical Performance of Nano Plus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

Condition:   Coronary Artery Disease
Intervention:   Device: Nano
Sponsors:   Xijing Hospital;   The First Affiliated Hospital with Nanjing Medical University
Recruiting - verified October 2016

DISsection RE-entry Evaluation With Absorb Bioresorbable Vascular Scaffolds in CTO.

Condition:   Coronary Artery Disease
Intervention:   Device: CTO PCI using Absorb Bioresorbable Vascular Scaffolds
Sponsors:   Belfast Health and Social Care Trust;   Bristol Royal Infirmary;   Golden Jubilee National Hospital;   Royal Infirmary of Edinburgh
Recruiting - verified October 2016

Early Versus Late Sustained Low Efficiency Dialysis in Critically Ill Cirrhotics With Septic Shock and Acute Kidney Injury

Condition:   Cirrhotics With Septic Shock and Acute Kidney Injury
Interventions:   Biological: Early Group CRRT;   Biological: Late Group CRRT
Sponsor:   Institute of Liver and Biliary Sciences, India
Not yet recruiting - verified October 2016

Clinical Study Evaluating Two Treatment Protocols for Immunosuppresive Drugs. Looking at 3-year Incidence of CLAD.

Conditions:   Lung Transplantation;   Allografts
Interventions:   Drug: Cyclosporine;   Drug: Mycophenolate mofetil (MMF);   Drug: Rabbit Anti thymocyte globuline;   Drug: Corticosteroids;   Drug: Tacrolimus
Sponsor:   Vastra Gotaland Region
Not yet recruiting - verified October 2016

Safe Use of Speaking Valve in Children During Sleep Using Trans-tracheal Pressure Measurement

Conditions:   Chronic Lung Disease of Prematurity;   Chronic Respiratory Failure
Sponsor:   St Mary's Hospital for Children
Completed - verified October 2016

Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)

Conditions:   Atrial Fibrillation;   End-stage Kidney Disease
Interventions:   Drug: Apixaban;   Drug: Phenprocoumon
Sponsors:   German Atrial Fibrillation Network;   Bristol-Myers Squibb;   Pfizer
Not yet recruiting - verified October 2016

CardioSmart Points

Log in to Check Your Balance
and Go Shopping

Learn how to earn more CardioSmart Points